Want to see JP:7975 full AI Analyst Report?
Top Page
LIHIT LAB., INC.
(7975)
Select Model
Select Model
Rating:47Neutral
Price Target:
¥1,047.00
▼(-16.04% Downside)
Action:Reiterated
Date:04/10/26
The score is held down primarily by inconsistent profitability and weak/volatile cash generation (including negative free cash flow in multiple years and a large deficit in 2026), despite a solid, low-leverage balance sheet. Technicals add caution due to a below-average trend and negative MACD, while valuation is mixed with a modest dividend yield offset by a relatively high P/E given recent earnings instability.
Positive Factors
Conservative balance sheet
Low leverage and a sizable equity base provide durable financial flexibility: the company can fund operations, absorb downturns in office-supply demand, and access credit without pressuring cash flows. This reduces insolvency risk and supports long-term strategic choices and investment capacity.
Negative Factors
Negative and volatile free cash flow
Repeated negative free cash flow and a very large 2026 deficit signal weak cash conversion or heavy outflows that impair reinvestment capacity, dividend sustainability, and reduce buffer against shocks. Persistent FCF shortfalls raise reliance on external financing or equity, increasing long-term financial risk.
Read all positive and negative factors
Positive Factors
Negative Factors
Conservative balance sheet
Low leverage and a sizable equity base provide durable financial flexibility: the company can fund operations, absorb downturns in office-supply demand, and access credit without pressuring cash flows. This reduces insolvency risk and supports long-term strategic choices and investment capacity.
Read all positive factors
LIHIT LAB., INC. (7975) vs. iShares MSCI Japan ETF (EWJ)
Market Cap
¥3.72B
Dividend Yield2.03%
Average Volume (3M)833.00
Price to Earnings (P/E)28.3
Beta (1Y)0.15
Revenue Growth-1.38%
EPS Growth-64.66%
CountryJP
Employees591
SectorGeneral
Sector StrengthN/A
IndustryBusiness Equipment & Supplies
Share Statistics
EPS (TTM)39.32
Shares Outstanding3,815,700
10 Day Avg. Volume1,000
30 Day Avg. Volume833
Financial Highlights & Ratios
PEG Ratio-0.75
Price to Book (P/B)0.38
Price to Sales (P/S)0.46
P/FCF Ratio-3.08
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
LIHIT LAB., INC. Business Overview & Revenue Model
Company Description
Lihit Lab., Inc., founded in Osaka, Japan, in 1938, manufactures and distributes a comprehensive range of office supplies both domestically and internationally. Their extensive product portfolio includes an array of filing and organizational solut...
How the Company Makes Money
The company primarily makes money by selling its stationery and office-supply products to business-to-business and consumer channels. Key revenue streams are product sales from (1) filing and document management goods (binders, folders, files, cas...
LIHIT LAB., INC. Financial Statement Overview
Summary
Income Statement
46
Neutral
Balance Sheet
74
Positive
Cash Flow
33
Negative
| Breakdown | TTM | Feb 2026 | Feb 2025 | Feb 2024 | Feb 2023 | Feb 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 9.20B | 9.12B | 9.22B | 8.80B | 8.51B | 8.69B |
| Gross Profit | 3.11B | 3.00B | 2.88B | 2.52B | 2.50B | 2.90B |
| EBITDA | 467.78M | 306.06M | 822.07M | 174.54M | 261.38M | 725.53M |
| Net Income | 133.41M | 67.07M | 411.57M | -93.73M | -24.41M | 262.51M |
Balance Sheet | ||||||
| Total Assets | 13.68B | 13.52B | 13.43B | 13.12B | 13.03B | 13.62B |
| Cash, Cash Equivalents and Short-Term Investments | 1.19B | 728.51M | 2.33B | 1.24B | 1.08B | 2.26B |
| Total Debt | 254.00M | 282.00M | 437.50M | 751.50M | 445.00M | 698.00M |
| Total Liabilities | 2.64B | 2.54B | 2.79B | 2.88B | 2.81B | 3.51B |
| Stockholders Equity | 11.04B | 10.98B | 10.64B | 10.24B | 10.22B | 10.11B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | -1.36B | 17.92M | -196.64M | -825.63M | 608.64M |
| Operating Cash Flow | 0.00 | 47.73M | 290.49M | 663.33M | -745.70M | 720.74M |
| Investing Cash Flow | 0.00 | -1.40B | 1.18B | -726.91M | -112.96M | -127.15M |
| Financing Cash Flow | 0.00 | -241.69M | -400.05M | 220.14M | -339.35M | -139.16M |
LIHIT LAB., INC. Technical Analysis
Neutral
1247.00
Price Trends
1109.32
Negative
1153.96
Negative
1180.23
Negative
Market Momentum
-1.61
Negative
53.12
Neutral
34.74
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For JP:7975, the sentiment is Neutral. The current price of 1247 is above the 20-day moving average (MA) of 1078.15, above the 50-day MA of 1109.32, and above the 200-day MA of 1180.23, indicating a neutral trend. The MACD of -1.61 indicates Negative momentum. The RSI at 53.12 is Neutral, neither overbought nor oversold. The STOCH value of 34.74 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Neutral sentiment for JP:7975.
LIHIT LAB., INC. Peers Comparison
UnderperformOutperform
Sector (55)
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
76 Outperform | ¥212.77B | 15.56 | ― | 2.56% | 1.83% | -7.02% | |
72 Outperform | ¥139.66B | 20.20 | ― | 2.09% | 0.66% | -30.89% | |
65 Neutral | ¥39.31B | 23.32 | ― | 1.77% | 2.05% | -15.62% | |
64 Neutral | ¥361.56B | 17.12 | 8.83% | 2.33% | 7.82% | 13.39% | |
61 Neutral | ¥21.98B | 57.16 | ― | 1.69% | -2.48% | 161.85% | |
55 Neutral | $6.65B | 3.83 | -15.92% | 6.20% | 10.91% | 7.18% | |
47 Neutral | ¥3.72B | 28.28 | ― | 2.03% | -1.38% | -64.66% |
* General Sector Average
JP:7975
LIHIT LAB., INC.
1,104.00
-29.56
-2.61%
JP:7984
Kokuyo Co
847.80
-23.60
-2.71%
JP:4218
Nichiban Co., Ltd.
1,894.00
40.32
2.17%
JP:7846
Pilot Corporation
1,763.50
406.66
29.97%
JP:7962
King Jim Co., Ltd.
776.00
-46.91
-5.70%
JP:7976
Mitsubishi Pencil Company, Limited
2,675.00
676.53
33.85%
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.